LIO
All-in-one platform for inpatient mental health care with digital rounding, ambient monitoring and compliance reporting
Company profile
Company profile
LIO (formerly Oxehealth) is a health technology company specializing in intelligent patient monitoring for inpatient mental health facilities. Founded in 2012 at the University of Oxford's Institute of Biomedical Engineering under the leadership of Professor Lord Lionel Tarassenko, the company developed a pioneering approach to contactless patient monitoring that established an entirely new category of health technology. The LIO platform integrates three core capabilities: digital rounding for efficient data collection and protocol adherence, ambient monitoring using ceiling-mounted infrared cameras and AI-powered analysis to provide continuous patient insights without wearables or wires, and compliance reporting that gives leaders visibility into operations and care quality. The system captures vital signs, monitors patient activity, tracks sleep patterns, and provides safety notifications—all through contactless technology that prioritizes patient dignity and privacy. LIO serves mental health providers across the US and UK, with over 100 customer sites and 5,000 installations supporting more than 100 million hours of patient care. The platform has been developed through 15+ years of collaboration with mental health care providers and co-created with patients, carers, clinicians, and leaders. Clinical evidence demonstrates significant improvements in safety outcomes, including 44% reduction in self-harm, 48% decrease in falls, 37% fewer assaults, and 71% reduction in 1:1 observations. The company holds 19 patents and has published over 20 peer-reviewed studies validating its real-world impact.
Company description Oxehealth official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: All EHR systems (seamless integration claimed).
Company milestones
Rebranded from Oxehealth to LIO. 50% of NHS mental health trusts now partner with the company. Over 100 customer sites with 5,000 installations supporting 100M+ hours of patient care.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
All-in-one platform for inpatient mental health care with digital rounding, ambient monitoring and compliance reporting
Contactless patient monitoring with AI-powered vision technology for mental health safety
Comprehensive compliance dashboards with audit trails and automated reporting for mental health facilities
Fast, intuitive digital rounding with time-stamped data entry and spot-check vitals
Electronic observations module for mental health care
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of psychiatric and mental health nursing · Aug 1, 2024
Non-contact monitoring to support care in acute inpatient mental health.Journal of mental health (Abingdon, England) · Jun 1, 2024
Remote vision-based digital patient monitoring of pulse and respiratory rates in acute medical wards.Thorax · Mar 15, 2024
Non-contact physiological monitoring of post-operative patients in the intensive care unit.NPJ digital medicine · Jan 13, 2022
Non-contact vital sign monitoring of patients in an intensive care unit: A human factors analysis of staff expectations.Applied ergonomics · Jan 1, 2021
Introducing artificial intelligence in acute psychiatric inpatient care: qualitative study of its use to conduct nursing observations.Evidence-based mental health · Feb 1, 2020
Clinical validation
No linked records are currently available.
Regulatory
K251200 · 510k · Feb 2, 2026
Vital SignsK243687 · 510k · Aug 27, 2025
Oxevision Sleep DeviceK233618 · 510k · Apr 3, 2024
Oxehealth Vital SignsK220899 · 510k · Apr 29, 2022
Vital SignsK211906 · 510k · Jul 20, 2021
Oxehealth Vital SignsDEN200019 · De Novo · Mar 26, 2021
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Ndebele et al. 2024, Journal of Mental Health
Wright & Singh 2022, Journal of Patient Safety
Ndebele et al. 2022, Journal of Psychiatric Intensive Care
Wright & Singh 2022, Journal of Patient Safety
Buckley et al. 2024, PLOS Digital Health
Optimization of 1:1 observation staffing through ambient monitoring technology
71% reduction in 1:1 observations
Reduction in self-harm incidents through ambient monitoring and digital rounding
44% reduction in self-harm
Implementation of LIO platform for equitable, safe and inclusive behavioral health care delivery
Enhanced quality and patient experience with less intrusive and safer care
05 · Leadership
Leadership profiles and professional links from the current Company record.
Todd Haedrich
CEO
James Ede-Golightly
Chairperson
Glenn Blatz
VP Sales
Sophie Davies
VP of Customer Success and Professional Services
Julian Dixon
VP of Engineering
Ben Walsh
VP Marketing
Charlotte Wood
VP Corporate Development
Danny Rose
Director of Finance
06 · Company updates
Recent articles published on Oxehealth's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.